ArticleOncotarget2019

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation.

Aaditya Khatri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.